{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:04:16Z","timestamp":1781201056465,"version":"3.54.1"},"reference-count":65,"publisher":"The Society for Free Radical Research Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2020]]},"DOI":"10.3164\/jcbn.20-89","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T22:08:10Z","timestamp":1601417290000},"page":"248-256","source":"Crossref","is-referenced-by-count":19,"title":["Walnut polyphenol extracts inhibit &lt;i&gt;Helicobacter pylori&lt;\/i&gt;-induced STAT3&lt;sup&gt;Tyr705&lt;\/sup&gt; phosphorylation through activation of PPAR-\u03b3 and SOCS1 induction"],"prefix":"10.3164","volume":"67","author":[{"given":"Jong Min","family":"Park","sequence":"first","affiliation":[{"name":"College of Oriental Medicine, Daejeon University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Min","family":"An","sequence":"additional","affiliation":[{"name":"CHA Cancer Preventive Research Center, CHA Bio Complex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Min","family":"Han","sequence":"additional","affiliation":[{"name":"Western Seoul Center, Korea Basic Science Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joon","family":"Surh","sequence":"additional","affiliation":[{"name":"College of Pharmacy Seoul National University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Jin","family":"Hwang","sequence":"additional","affiliation":[{"name":"Medpacto Research Institute, Medpacto Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Medpacto Research Institute, Medpacto Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Baik","family":"Hahm","sequence":"additional","affiliation":[{"name":"CHA Cancer Preventive Research Center, CHA Bio Complex"},{"name":"Medpacto Research Institute, Medpacto Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Choi IJ, Kook MC, Kim YI, et al. <i>Helicobacter pylori<\/i> therapy for the prevention of metachronous gastric cancer. N Engl J Med 2018; 378: 1085\u20131095.","DOI":"10.1056\/NEJMoa1708423"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Eid R, Moss SF. <i>Helicobacter pylori<\/i> infection and the development of gastric cancer. N Engl J Med 2002; 346: 65\u201367.","DOI":"10.1056\/NEJM200201033460115"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Zullo A, Hassan C, Morini S. <i>Helicobacter pylori<\/i> infection and the development of gastric cancer. N Engl J Med 2002; 346: 65\u201367.","DOI":"10.1056\/NEJM200201033460115"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ishii Y, Shibata W, Sugimori M, et al. Activation of signal transduction and activator of transcription 3 signaling contributes to <i>Helicobacter<\/i>-associated gastric epithelial proliferation and inflammation. Gastroenterol Res Pract 2018; 2018: 9050715.","DOI":"10.1155\/2018\/9050715"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Cao S, Zhu C, Feng J, et al. <i>Helicobacter hepaticus<\/i> infection induces chronic hepatitis and fibrosis in male BALB\/c mice via the activation of NF-kappaB, Stat3, and MAPK signaling pathways. Helicobacter 2020; 25: e12677.","DOI":"10.1111\/hel.12677"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Piao JY, Lee HG, Kim SJ, et al. <i>Helicobacter pylori<\/i> activates IL-6-STAT3 signaling in human gastric cancer cells: potential roles for reactive oxygen species. Helicobacter 2016; 21: 405\u2013416.","DOI":"10.1111\/hel.12298"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Jeong M, Park JM, Han YM, et al. Dietary prevention of <i>Helicobacter pylori<\/i>-associated gastric cancer with kimchi. Oncotarget 2015; 6: 29513\u201329526.","DOI":"10.18632\/oncotarget.4897"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Owen KL, Brockwell NK, Parker BS. JAK-STAT signaling: a double-edged sword of immune regulation and cancer progression. Cancers (Basel) 2019; 11: 2002.","DOI":"10.3390\/cancers11122002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Xiong H, Du W, Sun TT, et al. A positive feedback loop between STAT3 and cyclooxygenase-2 gene may contribute to <i>Helicobacter pylori<\/i>-associated human gastric tumorigenesis. Int J Cancer 2014; 134: 2030\u20132040.","DOI":"10.1002\/ijc.28539"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Howlett M, Menheniott TR, Judd LM, Giraud AS. Cytokine signalling via gp130 in gastric cancer. Biochim Biophys Acta 2009; 1793: 1623\u20131633.","DOI":"10.1016\/j.bbamcr.2009.07.009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Bronte-Tinkew DM, Terebiznik M, Franco A, et al. <i>Helicobacter pylori<\/i> cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway <i>in vitro<\/i> and <i>in vivo<\/i>. Cancer Res 2009; 69: 632\u2013639.","DOI":"10.1158\/0008-5472.CAN-08-1191"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Cha B, Kim KH, Matsui H, Kim H. Expression of suppressors of cytokine signaling-3 in <i>Helicobacter pylori<\/i>-infected rat gastric mucosal RGM-1cells. Ann N Y Acad Sci 2007; 1096: 24\u201328.","DOI":"10.1196\/annals.1397.066"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Lee JS, Paek NS, Kwon OS, Hahm KB. Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling (SOCS) expression and signaling in <i>Helicobacter pylori<\/i> infection: a novel mechanism. J Gastroenterol Hepatol 2010; 25: 194\u2013202.","DOI":"10.1111\/j.1440-1746.2009.06127.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Sharma J, Larkin J 3rd. Therapeutic implication of SOCS1 modulation in the treatment of autoimmunity and cancer. Front Pharmacol 2019; 10: 324.","DOI":"10.3389\/fphar.2019.00324"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Yoshimura A, Suzuki M, Sakaguchi R, Hanada T, Yasukawa H. SOCS, Inflammation, and autoimmunity. Front Immunol 2012; 3: 20.","DOI":"10.3389\/fimmu.2012.00020"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Inagaki-Ohara K, Kondo T, Ito M, Yoshimura A. SOCS, inflammation, and cancer. JAKSTAT 2013; 2: e24053.","DOI":"10.4161\/jkst.24053"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Lee HJ, Han YM, An JM, et al. Role of omega-3 polyunsaturated fatty acids in preventing gastrointestinal cancers: current status and future perspectives. Expert Rev Anticancer Ther 2018; 18: 1189\u20131203.","DOI":"10.1080\/14737140.2018.1524299"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Han YM, Kim KJ, Jeong M, et al. Suppressed <i>Helicobacter pylori<\/i>-associated gastric tumorigenesis in Fat-1 transgenic mice producing endogenous \u03c9-3 polyunsaturated fatty acids. Oncotarget 2016; 7: 66606\u201366622.","DOI":"10.18632\/oncotarget.11261"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Park JM, Kwon SH, Han YM, Hahm KB, Kim EH. Omega-3 polyunsaturated fatty acids as potential chemopreventive agent for gastrointestinal cancer. J Cancer Prev 2013; 18: 201\u2013208.","DOI":"10.15430\/JCP.2013.18.3.201"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Anderson KJ, Teuber SS, Gobeille A, Cremin P, Waterhouse AL, Steinberg FM. Walnut polyphenolics inhibit <i>in vitro<\/i> human plasma and LDL oxidation. J Nutr 2001; 131: 2837\u20132842.","DOI":"10.1093\/jn\/131.11.2837"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting interleukin-6 signaling in clinic. Immunity 2019; 50: 1007\u20131023.","DOI":"10.1016\/j.immuni.2019.03.026"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Johnson DE, O&apos;Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol 2018; 15: 234\u2013248.","DOI":"10.1038\/nrclinonc.2018.8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A. Suppressors of cytokine signaling (SOCS) proteins and JAK\/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol 2011; 31: 980\u2013985.","DOI":"10.1161\/ATVBAHA.110.207464"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Chang HY, Lee HN, Kim W, Surh YJ. Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor \u03b3 activation. Life Sci 2015; 120: 39\u201347.","DOI":"10.1016\/j.lfs.2014.10.014"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Jeong M, Park JM, Han YM, et al. Dietary intervention of artemisia and green tea extracts to rejuvenate <i>Helicobacter pylori<\/i>-associated chronic atrophic gastritis and to prevent tumorigenesis. Helicobacter 2016; 21: 40\u201359.","DOI":"10.1111\/hel.12229"},{"key":"26","unstructured":"26 Jencks DS, Adam JD, Borum ML, Koh JM, Stephen S, Doman DB. Overview of current concepts in gastric intestinal metaplasia and gastric cancer. Gastroenterol Hepatol (N Y) 2018; 14: 92\u2013101."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Piazuelo MB, Correa P. Gastric cancer: overview. Colomb Med (Cali) 2013; 44: 192\u2013201.","DOI":"10.25100\/cm.v44i3.1263"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Balic JJ, Saad MI, Dawson R, et al. Constitutive STAT3 serine phosphorylation promotes <i>Helicobacter<\/i>-mediated gastric disease. Am J Pathol 2020; 190: 1256\u20131270.","DOI":"10.1016\/j.ajpath.2020.01.021"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Balic JJ, Garama DJ, Saad MI, et al. Serine-phosphorylated STAT3 promotes tumorigenesis via modulation of RNA polymerase transcriptional activity. Cancer Res 2019; 79: 5272\u20135287.","DOI":"10.1158\/0008-5472.CAN-19-0974"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Cha B, Lim JW, Kim H. Jak1\/Stat3 is an upstream signaling of NF-kappaB activation in <i>Helicobacter pylori<\/i>-induced IL-8 production in gastric epithelial AGS cells. Yonsei Med J 2015; 56: 862\u2013866.","DOI":"10.3349\/ymj.2015.56.3.862"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Gobert AP, Wilson KT. Polyamine- and NADPH-dependent generation of ROS during <i>Helicobacter pylori<\/i> infection: a blessing in disguise. Free Radic Biol Med 2017; 105: 16\u201327.","DOI":"10.1016\/j.freeradbiomed.2016.09.024"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Jackson CB, Judd LM, Menheniott TR, et al. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. J Pathol 2007; 213: 140\u2013151.","DOI":"10.1002\/path.2218"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Menheniott TR, Judd LM, Giraud AS. STAT3: a critical component in the response to <i>Helicobacter pylori<\/i> infection. Cell Microbiol 2015; 17: 1570\u20131582.","DOI":"10.1111\/cmi.12518"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Rizzuti D, Ang M, Sokollik C, et al. <i>Helicobacter pylori<\/i> inhibits dendritic cell maturation via interleukin-10-mediated activation of the signal transducer and activator of transcription 3 pathway. J Innate Immun 2015; 7: 199\u2013211.","DOI":"10.1159\/000368232"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Lee KS, Kalantzis A, Jackson CB, et al. <i>Helicobacter pylori<\/i> CagA triggers expression of the bactericidal lectin REG3\u03b3 via gastric STAT3 activation. PLoS One 2012; 7: e30786.","DOI":"10.1371\/journal.pone.0030786"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Kaebisch R, Mej\u00edas-Luque R, Prinz C, Gerhard M. <i>Helicobacter pylori<\/i> cytotoxin-associated gene A impairs human dendritic cell maturation and function through IL-10-mediated activation of STAT3. J Immunol 2014; 192: 316\u2013323.","DOI":"10.4049\/jimmunol.1302476"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Zhao J, Dong Y, Kang W, et al. <i>Helicobacter pylori<\/i>-induced STAT3 activation and signalling network in gastric cancer. Oncoscience 2014; 1: 468\u2013475.","DOI":"10.18632\/oncoscience.62"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Sun TT, Tang JY, Du W, et al. Bidirectional regulation between TMEFF2 and STAT3 may contribute to <i>Helicobacter pylori<\/i>-associated gastric carcinogenesis. Int J Cancer 2015; 136: 1053\u20131064.","DOI":"10.1002\/ijc.29061"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Giraud AS, Menheniott TR, Judd LM. Targeting STAT3 in gastric cancer. Expert Opin Ther Targets 2012; 16: 889\u2013901.","DOI":"10.1517\/14728222.2012.709238"},{"key":"40","unstructured":"40 Cha B, Lim JW, Kim KH, Kim H. 15-deoxy-D12,14-prostaglandin J2 suppresses RANTES expression by inhibiting NADPH oxidase activation in <i>Helicobacter pylori<\/i>-infected gastric epithelial cells. J Physiol Pharmacol 2011; 62: 167\u2013174."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Cha B, Kim KH, Kim H. 15-Deoxy-delta 12, 14,-prostaglandin J2 suppresses nuclear factor-kappaB-mediated apoptosis of <i>Helicobacter pylori<\/i>-infected gastric epithelial cells. Ann N Y Acad Sci 2009; 1171: 457\u2013463.","DOI":"10.1111\/j.1749-6632.2009.04706.x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Han YM, Park JM, Kang JX, et al. Mitigation of indomethacin-induced gastrointestinal damages in fat-1 transgenic mice via gate-keeper action of \u03c9-3-polyunsaturated fatty acids. Sci Rep 2016; 6: 33992.","DOI":"10.1038\/srep33992"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Ji HG, Piao JY, Kim SJ, et al. Docosahexaenoic acid inhibits <i>Helicobacter pylori<\/i>-induced STAT3 phosphorylation through activation of PPAR\u03b3. Mol Nutr Food Res 2016; 60: 1448\u20131457.","DOI":"10.1002\/mnfr.201600009"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Ying J, Qiu X, Lu Y, Zhang M. SOCS1 and its potential clinical role in tumor. Pathol Oncol Res 2019; 25: 1295\u20131301.","DOI":"10.1007\/s12253-019-00612-5"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Yeganeh M, Gui Y, Kandhi R, et al. Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1\/WAF1) in the liver. Oncogene 2016; 35: 4200\u20134211.","DOI":"10.1038\/onc.2015.485"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Beaurivage C, Champagne A, Tobelaim WS, Pomerleau V, Menendez A, Saucier C. SOCS1 in cancer: an oncogene and a tumor suppressor. Cytokine 2016; 82: 87\u201394.","DOI":"10.1016\/j.cyto.2016.01.005"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Krebs DL, Hilton DJ. SOCS: physiological suppressors of cytokine signaling. J Cell Sci 2000; 113 (Pt 16): 2813\u20132819.","DOI":"10.1242\/jcs.113.16.2813"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Chevrier M, Bobbala D, Villalobos-Hernandez A, et al. Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer. BMC Cancer 2017; 17: 157.","DOI":"10.1186\/s12885-017-3141-8"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Ilangumaran S, Rottapel R. Regulation of cytokine receptor signaling by SOCS1. Immunol Rev 2003; 192: 196\u2013211.","DOI":"10.1034\/j.1600-065X.2003.00020.x"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Hanada T, Kinjyo I, Inagaki-Ohara K, Yoshimura A. Negative regulation of cytokine signaling by CIS\/SOCS family proteins and their roles in inflammatory diseases. Rev Physiol Biochem Pharmacol 2003; 149: 72\u201386.","DOI":"10.1007\/s10254-003-0015-z"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Inagaki-Ohara K, Hanada T, Yoshimura A. Negative regulation of cytokine signaling and inflammatory diseases. Curr Opin Pharmacol 2003; 3: 435\u2013442.","DOI":"10.1016\/S1471-4892(03)00070-5"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Greenhalgh CJ, Miller ME, Hilton DJ, Lund PK. Suppressors of cytokine signaling: relevance to gastrointestinal function and disease. Gastroenterology 2002; 123: 2064\u20132081.","DOI":"10.1053\/gast.2002.37068"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Larsen L, R\u00f6pke C. Suppressors of cytokine signalling: SOCS. APMIS 2002; 110: 833\u2013844.","DOI":"10.1034\/j.1600-0463.2002.1101201.x"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Starr R, Willson TA, Viney EM, et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387: 917\u2013921.","DOI":"10.1038\/43206"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Herrero R, Park JY, Forman D. The fight against gastric cancer - the IARC Working Group report. Best Pract Res Clin Gastroenterol 2014; 28: 1107\u20131114.","DOI":"10.1016\/j.bpg.2014.10.003"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Nariman F, Eftekhar F, Habibi Z, Falsafi T. Anti-<i>Helicobacter pylori<\/i> activities of six Iranian plants. Helicobacter 2004; 9: 146\u2013151.","DOI":"10.1111\/j.1083-4389.2004.00211.x"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Hajimahmoodi M, Shams-Ardakani M, Saniee P, et al. <i>In vitro<\/i> antibacterial activity of some Iranian medicinal plant extracts against <i>Helicobacter pylori<\/i>. Nat Prod Res 2011; 25: 1059\u20131066.","DOI":"10.1080\/14786419.2010.501763"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Nakanishi M, Matz A, Klemashevich C, Rosenberg DW. Dietary walnut supplementation alters mucosal metabolite profiles during DSS-induced colonic ulceration. Nutrients 2019; 11: 1118.","DOI":"10.3390\/nu11051118"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Liu H, Wan Y, Wang Y, et al. Walnut polyphenol extract protects against fenitrothion-induced immunotoxicity in murine splenic lymphocytes. Nutrients 2018; 10: 1838.","DOI":"10.3390\/nu10121838"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Zhao Y, Fan C, Zhang A, et al. Walnut polyphenol extract protects against malathion- and chlorpyrifos-induced immunotoxicity by modulating TLRx-NOX-ROS. Nutrients 2020; 12: 616.","DOI":"10.3390\/nu12030616"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Bamberger C, Rossmeier A, Lechner K, et al. A walnut-enriched diet affects gut microbiome in healthy caucasian subjects: a randomized, controlled trial. Nutrients 2018; 10: 244.","DOI":"10.3390\/nu10020244"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Shin PK, Zoh Y, Choi J, Kim MS, Kim Y, Choi SW. Walnut phenolic extracts reduce telomere length and telomerase activity in a colon cancer stem cell model. Nutr Res Pract 2019; 13: 58\u201363.","DOI":"10.4162\/nrp.2019.13.1.58"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Koh SJ, Choi YI, Kim Y, et al. Walnut phenolic extract inhibits nuclear factor kappaB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice. Eur J Nutr 2019; 58: 1603\u20131613.","DOI":"10.1007\/s00394-018-1704-3"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Lee J, Kim YS, Lee J, et al. Walnut phenolic extract and its bioactive compounds suppress colon cancer cell growth by regulating colon cancer stemness. Nutrients 2016; 8: 439.","DOI":"10.3390\/nu8070439"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Chung J, Kim YS, Lee J, Lee JH, Choi SW, Kim Y. Compositional analysis of walnut lipid extracts and properties as an anti-cancer stem cell regulator via suppression of the self-renewal capacity. Food Sci Biotechnol 2016; 25: 623\u2013629.","DOI":"10.1007\/s10068-016-0087-6"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/67\/3\/67_20-89\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T03:38:46Z","timestamp":1723693126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/67\/3\/67_20-89\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.20-89","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}